Phase 4 Alzheimer's Disease Trial, Recruiting NCT03821857 Sponsor: Mayo Clinic Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 4 Alzheimer's Disease Trial, Recruiting

NCT03821857
Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women who previously took part in this study
  • People who are currently aged 60 years or older
  • People who completed chemotherapy or major surgery requiring general anaesthesia more than six months ago
  • People who are willing and able to sign a consent form agreeing to take part
  • Women who identify as African American
  • People who are currently aged 60 years or older
  • People who completed chemotherapy or major surgery requiring general anaesthesia more than six months ago
  • People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are not able to read and speak English
  • People who are currently in hospice care
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who have a heart condition called QT prolongation, if the tau imaging part of the study applies to them (confirm with trial site)
  • People connected to Mayo Clinic Jacksonville (confirm with trial site)
  • People who are not able to read and speak English
  • People who are currently in hospice care
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who have a heart condition called QT prolongation, if the tau imaging part of the study applies to them (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Principal Investigator: Kejal Kantarci, MD, Mayo Clinic

Phone: 507-293-9397

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Registry
ClinicalTrials.gov
Start date
27 June 2019
Est. completion
1 May 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

18F-Flortaucipir PET imaging; Pittsburgh compound-B PET imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov